PL413202A1 - Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application - Google Patents

Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application

Info

Publication number
PL413202A1
PL413202A1 PL413202A PL41320215A PL413202A1 PL 413202 A1 PL413202 A1 PL 413202A1 PL 413202 A PL413202 A PL 413202A PL 41320215 A PL41320215 A PL 41320215A PL 413202 A1 PL413202 A1 PL 413202A1
Authority
PL
Poland
Prior art keywords
esters
substances
application
dihydrohelenalin
helenalin
Prior art date
Application number
PL413202A
Other languages
Polish (pl)
Other versions
PL237808B1 (en
Inventor
Krystyna Kromer
Agata Kierasińska
Jerzy Wiśniewski
Dorota Porutała
Andrzej Gamian
Original Assignee
Uniwersytet Wrocławski
Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Wrocławski, Uniwersytet Medyczny Im. Piastów Śląskich We Wrocławiu filed Critical Uniwersytet Wrocławski
Priority to PL413202A priority Critical patent/PL237808B1/en
Publication of PL413202A1 publication Critical patent/PL413202A1/en
Publication of PL237808B1 publication Critical patent/PL237808B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób pozyskiwania helenaliny i dihydrohelenaliny oraz estrów tych substancji w kulturze in vitro A. montana, A. montana cv. Arbo, A. chamissonis oraz zastosowanie helenaliny i dihydrohelenaliny w przemyśle farmaceutycznym i w kosmetologii jako środków o właściwościach przeciwzapalnych, cytostatycznych, przeciwbólowych, przeciwobrzękowych, bakteriostatycznych i przeciwgrzybiczych.The subject of the application is a method for obtaining helenaline and dihydrohelenaline and esters of these substances in in vitro culture A. montana, A. montana cv. Arbo, A. chamissonis and the use of helenaline and dihydrohelenaline in the pharmaceutical industry and cosmetology as anti-inflammatory, cytostatic, analgesic, anti-edema, bacteriostatic and anti-fungal agents.

PL413202A 2015-07-20 2015-07-20 Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application PL237808B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL413202A PL237808B1 (en) 2015-07-20 2015-07-20 Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL413202A PL237808B1 (en) 2015-07-20 2015-07-20 Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application

Publications (2)

Publication Number Publication Date
PL413202A1 true PL413202A1 (en) 2017-01-30
PL237808B1 PL237808B1 (en) 2021-05-31

Family

ID=57867759

Family Applications (1)

Application Number Title Priority Date Filing Date
PL413202A PL237808B1 (en) 2015-07-20 2015-07-20 Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application

Country Status (1)

Country Link
PL (1) PL237808B1 (en)

Also Published As

Publication number Publication date
PL237808B1 (en) 2021-05-31

Similar Documents

Publication Publication Date Title
CY1120529T1 (en) FUMARS PRODUCTS AND THEIR USE IN EDUCATION OF VARIOUS DISEASES
AU2019268062A1 (en) Benzoquinolone inhibitors of VMAT2
NI201600071A (en) AUTOTAXIN INHIBITOR COMPOUNDS
DOP2015000304A (en) BROMODOMINIUM CRYSTAL INHIBITORS
EA201790649A1 (en) BENZE-SUBSTITUTED INDAZOLES AS BUB 1 INHIBITORS
AR100215A1 (en) ANTIBODY-DRUG CONJUGATES ANTI-PTK7
CL2015002194A1 (en) Erk inhibitors and their uses
CR20160222U (en) SOLID FORMS OF ACID {[- (3- CHLOROPHENYL) -3- HYDROXIPIRIDIN -2-CARBONIL] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
UY31277A1 (en) NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA -SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS
UY33863A (en) METHODS AND MEDICINES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
BR112016025792A2 (en) CMV treatment media and processes
MX2015009058A (en) Compositions and methods for treating chronic inflammation and inflammatory diseases.
CL2015002897A1 (en) Bace1 inhibitors
CL2015001772A1 (en) Pharmaceutical composition for the treatment of headache, and method of preparing it.
WO2015061686A3 (en) Retinoid x receptor-gamma agonists and retinoid x receptor-alpha antagonists for treatment of cancer
MX2020000135A (en) New quinolinone compounds.
UY37534A (en) METHOD FOR THE TREATMENT OF FIBROTIC DISEASES USING INTERFERON-LAMBDA
CL2012003265A1 (en) Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
CL2012003006A1 (en) Compounds derived from unsaturated steroid lactones in position 7 (8) and their pharmaceutically acceptable salts and stereoisomers; pharmaceutical composition that includes them; and its use for the treatment of cancer.
EA201792121A1 (en) PHARMACEUTICAL SALT FORMS OF SEMICARBAS-SENSITIVE AMINOXIDASE INHIBITOR (SSAO)
IT201600081379A1 (en) Pharmaceutical composition for use in the treatment of prostatic diseases.
TR201905218T4 (en) USEFUL VITANOLIDES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
PL413202A1 (en) Method for receiving helenalin and dihydrohelenalin and esters of these substances from in vitro cultures of Arnica and their application
EA201400444A1 (en) DERIVATIVES 2-OXOPYPERIDINYL